C-MER Eye
Providing ophthalmic, general medical and surgical services.
Launch date
Market cap
AUD478m
Enterprise valuation
AUD441m (Public information from Sep 2024)
Share price
HKD2.17 3309.HK
Hong Kong Island Hong Kong (HQ)
Financials
Estimates*
HKD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 576m | 700m | 1.1b | 1.7b | 1.9b |
% growth | - | 21 % | 59 % | 56 % | 11 % |
EBITDA | 139m | 123m | 176m | 266m | 366m |
% EBITDA margin | 24 % | 18 % | 16 % | 15 % | 19 % |
Profit | 41.4m | (6.2m) | 21.9m | (21.9m) | 62.0m |
% profit margin | 7 % | (1 %) | 2 % | (1 %) | 3 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | N/A | HKD388m | Private Placement VC |
Total Funding | AUD72.4m |
Related Content
Recent News about C-MER Eye
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by C-MER Eye
EditACQUISITION by Alcon May 2024